DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award

This grant funds preclinical therapeutic development for ALS, covering validation of lead compounds through FDA IND-enabling studies. It requires proof-of-concept efficacy in at least one ALS model and emphasizes mechanism-specific biomarker development to improve trial design and patient selection. Applicants with limited ALS experience should partner with experienced collaborators.

Amount: Not stated
Type: Grant

Key facts

Key facts for DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
Amount	Not stated
Issuer	Defense Health Agency Contracting Activity - DHACA
Who can apply	Any organisation
Sectors	Deep Tech
Deadline	Closed 30 Sep 2026

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 40 days ago

85 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unit	up to $234,460	Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit	up to $150,000	Closes 07 Dec 2026